Synthesis method of ketamine and derivatives and intermediates thereof
By optimizing the synthesis process of ketamine in a kettle reactor, the problems of high energy consumption and low yield in the prior art are solved, and the efficient and low-cost mass production of ketamine is achieved, which is suitable for industrial applications.
Patent Information
- Application Number
- CN202411120673.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-12-03
AI Technical Summary
The existing ketamine synthesis technology has high energy consumption, low atomic economy and low yield, making it difficult to achieve mass production, which limits its industrial application.
The kettle reactor is used to oxidize and rearrange the 2-chlorophenylcyclopentyl ketone to form 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone, then condense with the sulfonyl reagent, and then with the methyl The amine reaction produces ketamine, which improves the yield and purity of the product by optimizing reaction conditions such as temperature and pressure.
It realizes efficient synthesis of ketamine, simplifies the process flow, reduces production costs, is suitable for industrial mass production, and improves the purity and yield of the product.
Smart Images

Figure CN119059942A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of ketamine synthesis, and particularly relates to a method for synthesizing ketamine and derivatives and intermediates thereof. Background Art
[0002] Ketamine, whose chemical name is 2-o-chlorophenyl-2-methylaminocyclohexanone, was developed by Parker-Davis Pharmaceuticals (currently a subsidiary of Pfizer) in 1962. The ketamine used in clinical practice is a racemic form. Ketamine is an N-methyl-D-aspartate receptor (NMDA) receptor antagonist and an intravenous general anesthetic. It is clinically used as a surgical anesthetic or anesthesia induction agent and has a certain potential for psychological dependence. Ketamine has been used clinically since 1962. As the only intravenous anesthetic with analgesic and sedative effects, it can be used for both anesthesia induction and anesthesia maintenance. It is widely used in pediatric surgery, pericardial tamponade patient surgery, shock patients and other surgeries. In addition, studies have shown that ketamine can also effectively treat alcoholism. After alcoholics recover drinking-related memories and are injected with ketamine, their desire to drink will decrease rapidly, and alcohol intake will decrease steadily within 9 months.
[0003] Ketamine's clinical application is limited to a certain extent due to its long recovery time after administration and the presence of side effects on the mental and circulatory systems. However, it has significant clinical advantages for pediatric patients (anesthesia induction for pediatric trauma, heart disease, and the preferred anesthesia method for children at high risk of malignant hyperthermia), patients with unstable blood flow, and patients in shock.
[0004] Studies in recent years have found that ketamine can also have a rapid therapeutic effect on major depression. As early as 2000, Berman et al. reported that ketamine has a rapid therapeutic effect on patients with depression; Murrough et al. reported that ketamine is more effective in treating depression than midazolam; in addition, unlike midazolam, adjuvant treatment with ketamine can significantly reduce suicidal tendencies in patients with depression. It is reported that for patients with difficult-to-treat unipolar and bipolar depression, ketamine can effectively improve the main symptoms of patients, including low mood and suicidal thoughts.
[0005] Ketamine is a racemate composed of (S)-ketamine and (R)-ketamine. Since (S)-ketamine has a 3-4 times higher affinity for N-methyl-D-aspartate receptors (NMDAR) than (R)-ketamine, and (S)-ketamine is metabolized faster in vivo than (R)-ketamine, it is developed as an antidepressant. On March 5, 2019, the antidepressant esketamine nasal spray developed by Janssen was approved for marketing by the US FDA. The current industrial preparation method of esketamine is the chiral resolution of racemic ketamine.
[0006] In recent years, research on ketamine's in vivo metabolite (S)-norketamine has become increasingly popular. Studies have found that (S)-norketamine has a better antidepressant effect than (S)-ketamine and has the advantage of fewer side effects.
[0007] Regarding the synthesis of ketamine, there are several synthesis strategies in the prior art. Stevens et al. first published a method for synthesizing ketamine. Synthesis route 1 is shown below:
[0008]
[0009] This route uses 4 as the starting substrate, which is brominated with CuBr2 to obtain 5, and then reacts with methylamine to generate hydroxyimine 6, and finally rearranges at high temperature to obtain ketamine hydrochloride Ib. The total yield is about 27.8%. The bromination reagents used in the preparation of intermediate 5 are CuBr2, NBS, bromine and other bromination reagents, which have low atomic utilization and high environmental pollution. Although the yield is high, the reaction system contains a large amount of copper ions, and industrial waste residues such as cuprous bromide will be produced during post-treatment, increasing the environmental protection cost of the enterprise. The methylation reaction is to react with excess liquid methylamine at -40°C, which is ultra-low temperature, and there is the problem of inconvenient access and storage of methylamine; the final high-temperature rearrangement reaction requires a high temperature of 170-180°C, high energy consumption, and the resulting product is easy to carbonize.
[0010] Zhang et al. reported a method for synthesizing 2-o-chlorophenyl-2-methylaminocyclohexanone using another strategy. Synthesis route 2 is shown below:
[0011]
[0012] This route uses compound 7 as the starting substrate, which is nitrated and reduced to obtain norketamine, and then reduced and aminated with formaldehyde to obtain ketamine Ib. Although the number of reaction steps is small, the starting substrate 7 is not easy to obtain and has not been industrialized. The cost of raw materials is too high. At the same time, the yield of each step is low. In addition, more metal reagents are used, which increases the production cost, thus limiting its industrial production.
[0013] In 2019, Monbaliu JC et al. reported a method for synthesizing ketamine through microchannel reaction technology. Synthesis route three is shown below:
[0014]
[0015] This route uses intermediate 4 as the starting substrate, and 9 is oxidized under the conditions of oxygen, potassium hydroxide and phosphite. The oxidation reaction in this step has a short residence time in the microchannel reactor, so the obtained product 9 has basically no rearrangement impurities. Subsequently, under the action of triisopropyl borate and methylamine ethanol solution, intermediate 6 is obtained, and finally racemic ketamine is rearranged at high temperature. This route can produce ketamine hydrochloride in three steps, but the high-temperature rearrangement in the last step requires 180°C and 35atm. The high temperature and high pressure conditions greatly increase the energy consumption, that is, the equipment cost, and the yield is only 62%. In addition, the reaction is carried out in a microchannel, which requires relatively expensive supporting equipment. The daily production is only 71g, and the cost is greatly increased, so it is not conducive to its industrial production.
[0016] In summary, the current synthetic routes of ketamine and (S)-ketamine have technical problems such as high energy consumption, low atom economy, low yield, and difficulty in mass production. However, the current clinical demand for ketamine and (S)-ketamine is large, so there is an urgent need to develop an efficient synthetic route for ketamine suitable for industrial production. Summary of the invention
[0017] In view of the problems in the background technology, the object of the present invention is to provide a method for synthesizing ketamine and its derivatives and intermediates, which is used for the synthesis of ketamine and its derivatives, so as to make the production cost of ketamine and its derivatives lower and the reaction conditions milder.
[0018] To achieve the above object, the present invention proposes the following technical solutions:
[0019] A method for synthesizing a ketamine intermediate compound, the method comprising the following steps:
[0020] (i) 2-chlorophenylcyclopentyl ketone (4) is oxidized by an oxidant and rearranged to generate 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III); the reaction temperature is 10-80°C;
[0021] Although the reaction conditions are similar to the first step of route three, route three is in a microchannel reactor, while the present application is in a tank reactor. Due to the differences between microchannel reactors and tank reactors and the different reaction times, a compound as shown in formula (III) is obtained under the reaction conditions shown in the present invention. In the microchannel reactor, the equivalent of the base used is 0.5eq, while in the present application it is 1.0eq; at the same time, when reacting in the microchannel reactor, 1.0eq of PEG-400 is added, which has the effect of inhibiting ring expansion rearrangement, while in the present application it is not added in the tank reaction; in terms of reaction time, the reaction time in the microchannel is 5min, while in the tank reaction of the present application it is 48h. There is a pressure of 11bar during the reaction in the microchannel, while the tank reaction in the present application is under normal pressure.
[0022] (ii) condensing the 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) obtained in step (i) with a sulfonylating agent in a solvent to form a sulfonate ester, thereby obtaining the ketamine intermediate compound (II); the reaction temperature is -30-60°C;
[0023] The reaction route is as follows:
[0024]
[0025] As a preferred solution, the oxidant used in the oxidation reaction in step (i) is oxygen or air.
[0026] As a preferred embodiment, the base used in the oxidation reaction in step (i) is potassium hydroxide, potassium carbonate, potassium bicarbonate, cesium carbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium tert-butoxide or sodium tert-butoxide.
[0027] As a preferred solution, the reducing agent used in the oxidation reaction in step (i) is sodium sulfite, sodium bisulfite, triethyl phosphite, sodium phosphite, trimethyl phosphite, triisopropyl phosphite, sodium thiosulfate, etc. More preferably, the reducing agent is triethyl phosphite, trimethyl phosphite or triisopropyl hydrochloride.
[0028] The solvent used in step (i) is dimethyl sulfoxide, N,N-dimethylformamide, ethanol, methanol, isopropanol, tetrahydrofuran, acetonitrile, ethyl acetate, acetone, etc.
[0029] As a preferred solution, the reaction time of step (i) is 24h-96h.
[0030] As a preferred solution, in step (i), the molar ratio of 2-chlorophenylcyclopentyl ketone to the reducing agent is 1:1.5, and the molar ratio of 2-chlorophenylcyclopentyl ketone to the base is 1:1.
[0031] As a preferred solution, in step (ii), the molar ratio of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone to the sulfonylating agent is 1:3.
[0032] As a preferred solution, the reaction time of step (ii) is 1 h-8 h.
[0033] As a preferred embodiment, the sulfonylating agent in step (ii) is methanesulfonic acid, methanesulfonyl chloride, benzenesulfonyl chloride, thionyl chloride or p-toluenesulfonyl chloride.
[0034] The solvent used in step (ii) is dimethyl sulfoxide, N,N-dimethylformamide, acetone, tetrahydrofuran, ethanol, dichloromethane and ethyl acetate.
[0035] A method for synthesizing ketamine using the ketamine intermediate compound obtained by the method as described above, the method comprising the following steps:
[0036] (iii) reacting the ketamine intermediate compound II with a methylamination reagent to produce ketamine Ib; the reaction temperature is -10-60°C;
[0037] The reaction route is as follows:
[0038]
[0039] The intermediate compound II for synthesizing ketamine can be directly reacted with a methylamination reagent without separation to generate the ketamine molecule Ib.
[0040] As a preferred embodiment, the molar ratio of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone in step (ii) to the methyl amination reagent in step (iii) is 1:10.
[0041] As a preferred solution, the methylamine reagent is methylamine-ethanol solution, methylamine-methanol solution, methylamine tetrahydrofuran solution, methylamine aqueous solution or liquid methylamine.
[0042] As a preferred solution, the reaction time of step (iii) is 1.5h-10h.
[0043] A method for synthesizing norketamine using the ketamine intermediate compound obtained by the method as described above, the method comprising the following steps:
[0044] (iv) reacting the ketamine intermediate compound II with an amination reagent to produce norketamine Ia; the reaction temperature is -10-60°C;
[0045] The reaction route is as follows:
[0046]
[0047] The intermediate compound II for synthesizing norketamine can be directly reacted with an aminating agent without separation to generate the norketamine molecule Ia.
[0048] As a preferred embodiment, the molar ratio of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone in step (ii) to the amination reagent in step (iv) is 1:10.
[0049] As a preferred solution, the amination agent is ammonia gas, ammonia-methanol solution, ammonia-ethanol solution, ammonia-isopropanol solution or liquid ammonia-tetrahydrofuran solution.
[0050] As a preferred solution, the reaction time of step (iv) is 2h-6h.
[0051] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0052] The invention provides a novel and efficient method for synthesizing ketamine and norketamine. The method is simple, has mild reaction conditions, avoids high-temperature reaction at 180°C, is easy to operate, has low raw material cost, and is suitable for industrial mass production of ketamine.
[0053] Compared with the route 3 of the prior art, although the reagents used in the oxidation process are basically the same, there are differences in the same reaction in the microchannel reactor and the autoclave reactor, and the present invention changes the reaction temperature so that the product of this step is completely converted into the target compound 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) required by the present invention. Subsequently, the present invention can smoothly obtain the target product ketamine with a yield of 83% through amination on the basis of III. The prior art route 3 still needs to be rearranged under high temperature and high pressure conditions to obtain ketamine. The reaction conditions have high requirements on equipment, and the yield is only 62%. Therefore, the new route of the present invention has greater advantages and stronger industrial prospects than the existing method.
[0054] The present invention can efficiently synthesize racemic ketamine, and then efficiently synthesize esketamine, a popular antidepressant currently on the market, through chiral resolution and racemization of (R)-ketamine. Therefore, the present invention has high practicality. BRIEF DESCRIPTION OF THE DRAWINGS
[0055] Figure 1 HPLC chart of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) prepared in Example 1;
[0056] Figure 2 This is the HPLC chart of ketamine (Ib) prepared in Example 1;
[0057] Figure 3 HPLC chart of norketamine (Ia) prepared in Example 2;
[0058] Figure 4 The single crystal image (1) of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) prepared in Example 1;
[0059] Figure 5 The single crystal image (2) of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) prepared in Example 1;
[0060] Figure 6 This is the H NMR spectrum of compound III prepared in Example 1;
[0061] Figure 7 This is the NMR carbon spectrum of compound III prepared in Example 1;
[0062] Figure 8 This is the H NMR spectrum (DMSO) of ketamine (Ⅰb) prepared in Example 1;
[0063] Fig. 9 This is the NMR carbon spectrum (DMSO) of ketamine (Ⅰb) prepared in Example 1;
[0064] Fig.10 This is the NMR DEPT spectrum (DMSO) of ketamine (Ⅰb) prepared in Example 1;
[0065] Fig.11 This is the H NMR spectrum of norketamine (Ia) prepared in Example 2;
[0066] Fig.12 This is the NMR carbon spectrum of norketamine (Ia) prepared in Example 2;
[0067] Fig.13 This is the DEPT spectrum of norketamine (Ia) prepared in Example 2. DETAILED DESCRIPTION
[0068] The present invention is further illustrated by the following examples, which are only used to more specifically illustrate the preferred embodiments of the present invention and are not used to limit the technical solutions of the present invention. The above-mentioned solutions of the present invention are all technical solutions that can achieve the purpose of the present invention. The temperatures and reagents used in the following examples can be replaced by the above-mentioned corresponding temperatures and reagents to achieve the purpose of the present invention.
[0069] In the following preparation examples, nuclear magnetic resonance was measured by a Varian Inova nuclear magnetic resonance spectrometer, TMS was used as an internal standard, and the unit of chemical shift was ppm.
[0070] The ketamine and norketamine products prepared in Examples 1-11 were tested for HPLC purity.
[0071] The test method is as follows:
[0072] The product purity is tested by a general C18 column, and the analysis method is as follows:
[0073] Chromatographic column: 150 mm × 4.6 mm × 3.5 μm, X-Bridge C18;
[0074] UV detector wavelength: 210nm;
[0075] Flow rate: 1.0 mL / min;
[0076] Column temperature: 35°C;
[0077] Mobile phase: Phase A is 10 mmol / L potassium dihydrogen phosphate aqueous solution / acetonitrile = 9:1; Phase B is acetonitrile.
[0078] The gradient elution method used is detailed in the following table:
[0079]
[0080]
[0081] Ketamine or norketamine prepared in Example 3-11 was tested by the above-mentioned HPLC method, indicating that the peak time and purity of the product were basically consistent with those of the products prepared in Example 1 and Example 2; therefore, the present invention no longer lists the HPLC test spectra one by one.
[0082] Example 1
[0083] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (4) (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add potassium hydroxide (2.7 g, 0.048 mol) and triethyl phosphite (12.0 g, 0.072 mol) and stir to dissolve, and heat to 30°C in an oxygen environment for 48 hours. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 mL of water is added dropwise to precipitate solids, stir at room temperature for 1 hour, filter, and dry at 50°C for 10 hours to obtain 8.9 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 83.0% and a purity of 97.15%.
[0084] The HPLC chart of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) is as follows Figure 1 shown.
[0085] The H NMR spectrum of compound III is as follows Figure 6 The specific data are as follows:
[0086] 1 H NMR(600MHz, CDCl3) δ7.68(dd,J=7.8,1.0Hz,1H),7.42–7.33(m,2H),7.28(ddd,J=21.5,10.7,4.3Hz,1H),4.51(s,1H) ,2.97(dt,J=17.7,6.6Hz,1H),2.68–2.54(m,1H),2.46(td,J=11.9,5.8Hz,1H),2.10–2.02(m,1H),1.85–1.71(m,4H).
[0087] The NMR carbon spectrum of compound III is as follows Figure 7 The specific data are as follows:
[0088] 13 C NMR (151MHz, CDCl3) δ212.59,137.51,133.93,131.29,129.72,128.64,127.08,80.56,41.82,38.75,29.47,22.77.
[0089] HRMS: C 12 H 13 O2NaCl,247.0509[M+Na] + , the single crystal of compound III is as follows Figure 4 and Figure 5 shown.
[0090] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.013 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, triethylamine (4.7 g, 0.047 mol) was added, and methanesulfonyl chloride (4.6 g, 0.04 mol) was added dropwise at -10°C for 1 h, and then 25%-30% methylamine-ethanol solution (23 mL, 0.13 mol) was added and the temperature was raised to 15°C for 3 h. After the reaction, 15 mL of water was added to the reaction solution, the organic solvent was concentrated under reduced pressure, and dichloromethane (20×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (15×2 mL), and 20 mL of dichloromethane was added to the aqueous phase after separation and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain 2.6 g of ketamine, with a yield of 85% and a purity of 99.48%.
[0091] Ketamine (Ib) HPLC chart Figure 2 shown.
[0092] The H NMR spectrum of ketamine (Ib) (DMSO) is as follows Figure 8 The specific data are as follows:
[0093] 1 H NMR(400MHz,MeOD)δ7.99(dd,J=6.1,2.4Hz,1H),7.70–7.62(m,3H),4.87(s,2H),3.52–3.38(m,1H),2. 63–2.52(m,2H),2.43(s,3H),2.21–2.13(m,1H),2.02–1.91(m,2H),1.80(qdd,J=12.9,9.2,4.2Hz,2H).
[0094] The NMR carbon spectrum (DMSO) of ketamine (Ⅰb) is as follows Fig. 9 As shown, the NMR DEPT spectrum (DMSO) is as follows Fig.10The specific data are as follows:
[0095] 13 C NMR (101MHz, MeOD) δ206.45 (s), 134.04 (s), 132.07 (s), 131.49 (d, J = 2.3Hz), 127. 96(s),127.42(s),71.87(s),38.98(s),35.75(s),29.21(s),26.30(s),20.97(s).
[0096] HRMS: C 13 H 17 ClNO, 238.0996[M+H] + .
[0097] Example 2
[0098] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add potassium hydroxide (2.7 g, 0.048 mol) and triethyl phosphite (12.0 g, 0.072 mol) and stir to dissolve, and heat to 40°C in an oxygen environment for 48 hours. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 mL of water is added dropwise to precipitate solids, which are filtered and dried at 50°C for 10 hours to obtain 8.8 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 82% and a purity of 98.35%.
[0099] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (6.0 g, 0.027 mol) was dissolved in 50 mL of tetrahydrofuran solution at room temperature, triethylamine (9.5 g, 0.094 mol) was added, methanesulfonyl chloride (9.2 g, 0.08 mol) was added dropwise at -10°C and reacted for 1 h, then ammonia-methanol solution (40 mL, 0.27 mol) was added and the temperature was raised to 15°C and reacted for 3 h. After the reaction, 30 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and dichloromethane (30×2 mL) was added to separate the liquids. The dichloromethane phase was washed with 1N HCl aqueous solution (30×2 mL), and 40 mL of dichloromethane was added to the aqueous phase after separation and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate and concentrated under reduced pressure to obtain 4.95 g of norketamine, with a yield of 83% and a purity of 96.8%.
[0100] HPLC chart of norketamine (Ⅰa) Figure 3 shown.
[0101] The H NMR spectrum of norketamine (Ia) is as follows Fig.11 The specific data are as follows:
[0102] 1 H NMR (600MHz, DMSO) δ8.82(s,12H),8.82(s,12H),7.90(dd,J=7.7,1.7Hz,4H),7.90(dd,J=7.7,1.7Hz,4H),7.62–7.51(m,12H ),7.61–7.52(m,12H),3.18(dd,J=14.3,2.7Hz,4H),2.48(dd,J=9.1,6.2Hz,11H),2.48(dd,J=9.1,6.2Hz,4H),2.40(td,J=1 2.5,5.9Hz,4H),2.40(td,J=12.5,5.9Hz,4H),2.03(dd,J=7.6,4.5Hz,4H),2.00(ddd,J=16.6,9.3,2.5Hz,7H),1.96(td,J=1 4.2,3.5Hz,4H),1.93(d,J=3.4Hz,1H),1.79(d,J=13.9Hz,4H),1.79(d,J=13.9Hz,4H),1.70–1.51(m,8H),1.71–1.49(m,8H).
[0103] The NMR carbon spectrum of norketamine (Ⅰa) is as follows Fig.12 As shown, the DEPT spectrum of norketamine (Ia) is as follows Fig.13 The specific data are as follows:
[0104] 13 C NMR (151MHz, DMSO) δ207.46,133.72,132.29,131.95,131.78,131.55,128.57,67.22,39.32,38.12,29.56,21.54.
[0105] HRMS: C 12 H 15 ClNO,224.0848[M+H] + .
[0106] Example 3
[0107] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add potassium carbonate (6.6 g, 0.048 mol) and sodium bisulfite (7.5 g, 0.072 mol) and stir to dissolve, and heat to 40°C in an oxygen environment for 24 hours. After the reaction is completed, concentrate about 70 mL of anhydrous ethanol under reduced pressure, add 300 mL of water dropwise to precipitate solids, filter by suction, and dry at 50°C for 10 hours to obtain 6.0 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 55.7% and a purity of 98.1%.
[0108] Step 2: Dissolve 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.013 mol) in 25 mL of tetrahydrofuran solution at room temperature, add triethylamine (4.7 g, 0.047 mol), add methanesulfonyl chloride (4.6 g, 0.04 mol) dropwise at -10°C and react for 1 h, then add 25%-30% methylamine-ethanol solution (23 mL, 0.13 mol) and heat to 30°C to react for 1.5 h. After the reaction, 15 mL of water was added to the reaction solution, which was concentrated under reduced pressure. Dichloromethane (15×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (15×2 mL). 20 mL of dichloromethane was added to the aqueous phase after separation and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution. The organic phase was dried over anhydrous sodium sulfate (1.2 g) and concentrated under reduced pressure to obtain 2.6 g of ketamine with a yield of 82% and a purity of 99.2%.
[0109] Example 4
[0110] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add cesium carbonate (15.6 g, 0.048 mol) and sodium sulfite (9.1 g, 0.072 mol) and stir to dissolve, and heat to 30°C in an air environment for 4 days. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 ml of water is added dropwise to precipitate solids, which are filtered and dried at 50°C for 10 h to obtain 4.0 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 37.1% and a purity of 95.0%.
[0111] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.013 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, triethylamine (4.7 g, 0.047 mol) was added, and methanesulfonyl chloride (4.6 g, 0.04 mol) was added dropwise at 0°C for 1 h, and then methylamine-ethanol solution (23 mL, 0.13 mol) was added and the temperature was raised to 0°C for 10 h. After the reaction, 15 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and dichloromethane (15×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (15×2 mL), and 20 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1.2 g), and concentrated under reduced pressure to obtain 2.4 g of ketamine, with a yield of 75.7% and a purity of 98.5%.
[0112] Example 5
[0113] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add potassium tert-butoxide (5.4 g, 0.048 mol) and triisopropyl phosphite (15.0 g, 0.072 mol) and stir to dissolve, and heat to 30°C in an oxygen environment for 24 hours. After the reaction is completed, concentrate about 70 mL of anhydrous ethanol under reduced pressure, add 300 ml of water dropwise to precipitate solids, filter, dry at 50°C for 10 hours, and obtain 4.5 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III) by column chromatography, with a yield of 42.1% and a purity of 96.1%.
[0114] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.013 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, triethylamine (4.7 g, 0.047 mol) was added, p-toluenesulfonyl chloride (7.6 g, 0.04 mol) was added dropwise at -20°C for 1 h, and then methylamine-ethanol solution (23 mL, 0.13 mol) was added and the temperature was raised to 15°C for 3 h. After the reaction, 15 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and dichloromethane (15×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (15×2 mL), and 20 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1.2 g), and concentrated under reduced pressure to obtain 2.3 g of ketamine, with a yield of 76% and a purity of 99.40%.
[0115] Example 6
[0116] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 70 mL of dimethyl sulfoxide solution at room temperature, add potassium bicarbonate (4.8 g, 0.048 mol) and trimethyl phosphite (8.9 g, 0.072 mol) and stir to dissolve, and heat to 30°C in an oxygen environment to react for 72 hours. After the reaction is completed, add 300 mL of water dropwise to precipitate the solid, filter it, dry it at 50°C, and then column chromatograph to obtain 3.0 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 28.1% and a purity of 95.5%.
[0117] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.013 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, triethylamine (4.7 g, 0.047 mol) was added, p-toluenesulfonyl chloride (7.6 g, 0.04 mol) was added dropwise at -10°C for 8 h, and then methylamine-ethanol solution (23 mL, 0.13 mol) was added and the temperature was raised to 15°C for 10 h. After the reaction, 15 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and dichloromethane (15×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (15×2 mL), and 20 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1.2 g), and concentrated under reduced pressure to obtain 0.4 g of ketamine, with a yield of 12.9% and a purity of 98.7%.
[0118] Example 7
[0119] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add cesium carbonate (15.6 g, 0.048 mol) and sodium thiosulfate (11.4 g, 0.072 mol) and stir to dissolve, and heat to 50°C in an oxygen environment for 24 hours. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 mL of water is added dropwise to precipitate solids, filter by suction, and dry at 50°C for 10 hours to obtain 4.4 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 41.2% and a purity of 97.15%.
[0120] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.0135 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, and methanesulfonic acid (3.8 g, 0.04 mol) was added dropwise, and the temperature was raised to 60°C for reaction for 2 h, and then methylamine-methanol solution (20 mL, 0.135 mol) was added and the temperature was raised to 15°C for reaction for 3 h. After the reaction, 20 mL of water was added to the reaction solution, and the mixture was concentrated under reduced pressure. Dichloromethane (30×2 mL) was added to separate the liquids, and the dichloromethane phase was washed with 1N HCl aqueous solution (30×2 mL). 20 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1 g), and concentrated under reduced pressure to obtain 1.5 g of norketamine, with a yield of 49.8% and a purity of 96.8%.
[0121] Example 8
[0122] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add sodium hydroxide (1.9 g, 0.048 mol) and sodium phosphite (15.5 g, 0.072 mol) and stir to dissolve, and heat to 30°C under oxygen conditions for 48 hours. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 mL of water is added dropwise to precipitate solids, which are filtered and dried at 50°C for 10 hours to obtain 3.4 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 31.9% and a purity of 96.2%.
[0123] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.0135 mol) was dissolved in 25 mL of tetrahydrofuran solution at room temperature, triethylamine (4.3 g, 0.047 mol) was added, p-toluenesulfonyl chloride (3.8 g, 0.04 mol) was added dropwise at 25°C and reacted for 5 h, then amine-ethanol solution (20 mL, 0.27 mol) was added and the temperature was raised to 15°C and reacted for 6 h. After the reaction, 30 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and dichloromethane (30×2 mL) was added to separate the liquids. The dichloromethane phase was washed with 1N HCl aqueous solution (30×2 mL), and 20 mL of dichloromethane was added to the aqueous phase after separation and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1 g) and concentrated under reduced pressure to obtain 0.8 g of norketamine, with a yield of 26.7% and a purity of 96.8%.
[0124] Example 9
[0125] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 70 mL N, N-dimethylformamide solution at room temperature, add sodium carbonate (5.1 g, 0.048 mol) and triethyl phosphite (12.0 g, 0.072 mol) and stir to dissolve, and heat to 50 ° C in an oxygen environment for 24 hours. After the reaction is completed, add 300 mL of water dropwise to precipitate solids, filter, and dry at 50 ° C for 10 hours to obtain 6.1 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 57.2% and a purity of 96.5%.
[0126] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (6.0 g, 0.027 mol) was dissolved in 50 mL of dichloromethane solution at room temperature, triethylamine (9.5 g, 0.094 mol) was added, methanesulfonyl chloride (9.2 g, 0.08 mol) was added dropwise at -10°C and reacted for 1 h, then amine-ethanol solution (50 mL, 0.38 mol) was added and the temperature was raised to 30°C and reacted for 2 h. After the reaction, 30 mL of water was added to the reaction solution, ethanol was concentrated under reduced pressure, dichloromethane (30×2 mL) was added, the dichloromethane phase was separated, and the dichloromethane phase was washed with 1N HCl aqueous solution (30×2 mL), 40 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (3 g), and concentrated under reduced pressure to obtain 4.8 g of norketamine, with a yield of 81.1% and a purity of 97.2%.
[0127] Example 10
[0128] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of methanol solution at room temperature, add potassium hydroxide (2.7 g, 0.048 mol) and triethyl phosphite (12.0 g, 0.072 mol) and stir to dissolve, and heat to 60°C in an air environment for 4 days. After the reaction is completed, concentrate about 70 mL of methanol under reduced pressure, add 300 mL of water dropwise to precipitate solids, filter by suction, and dry at 50°C for 10 hours to obtain 5.5 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 51.1% and a purity of 97.1%.
[0129] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (3.0 g, 0.0135 mol) was dissolved in 25 mL of ethyl acetate solution at room temperature, triethylamine (2.0 g, 0.02 mol) was added, and methanesulfonyl chloride (1.5 g, 0.0135 mol) was added dropwise at -10°C for 3 h, and then amine-methanol solution (20 mL, 0.14 mol) was added and the temperature was raised to 15°C for 5 h. After the reaction, 30 mL of water was added to the reaction solution, which was concentrated under reduced pressure, and ethyl acetate (30×2 mL) was added for separation. The ethyl acetate phase was washed with 1N HCl aqueous solution (30×2 mL), and 40 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (1 g), and concentrated under reduced pressure to obtain 2.5 g of norketamine, with a yield of 83.1% and a purity of 96.3%.
[0130] Embodiment 11
[0131] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (10.0 g, 0.048 mol) in 100 mL of anhydrous ethanol solution at room temperature, add cesium carbonate (15.6 g, 0.048 mol) and triethyl phosphite (12.0 g, 0.072 mol) and stir to dissolve, and heat to 45°C in an oxygen environment for 24 hours. After the reaction is completed, about 70 mL of anhydrous ethanol is concentrated under reduced pressure, 300 mL of water is added dropwise to precipitate solids, filter by suction, and dry at 50°C for 10 hours to obtain 8.9 g of 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (III), with a yield of 83.4% and a purity of 99.5%.
[0132] Step 2: 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone (6.0 g, 0.027 mol) was dissolved in 50 mL of tetrahydrofuran solution at room temperature, triethylamine (9.5 g, 0.094 mol) was added, and methanesulfonyl chloride (3.1 g, 0.08 mol) was added dropwise at -10°C for 2 h, and then ammonia gas was introduced into the reaction solution and the temperature was raised to 15°C for 3 h. After the reaction, 30 mL of water was added to the reaction solution, and the solution was concentrated under reduced pressure, and dichloromethane (30×2 mL) was added for separation. The dichloromethane phase was washed with 1N HCl aqueous solution (30×2 mL), and 40 mL of dichloromethane was added to the aqueous phase after separation, and the pH was adjusted to 8-9 with saturated sodium carbonate aqueous solution, and the organic phase was dried with anhydrous sodium sulfate (3 g), and concentrated under reduced pressure to obtain 5.3 g of norketamine, with a yield of 89.1% and a purity of 97.8%.
[0133] Comparative Example 12
[0134] Step 1: Dissolve 2-chlorophenylcyclopentyl ketone (4) (1.0 g, 0.0048 mol) in 10 mL of anhydrous ethanol at room temperature, add potassium hydroxide (0.27 g, 0.0048 mol) and triethyl phosphite (1.2 g, 0.0072 mol) and stir to dissolve, heat to 30°C in a nitrogen atmosphere and react for 48 h. No target product is generated by HPLC. This indicates that the oxidant in this step is oxygen.
Claims
1. A method for synthesizing a ketamine intermediate compound, It is characterized in that The method comprises the following steps: (i) 2-chlorophenylcyclopentyl ketone is oxidized by an oxidant and rearranged to generate 2-(2-chlorophenyl)-2-hydroxycyclohexyl ketone; the reaction temperature is 10-80°C; (ii) condensing the 2-(2-chlorophenyl)-2-hydroxycyclohexanone obtained in step (i) with a sulfonylating agent in a solvent to form a sulfonate, thereby obtaining the ketamine intermediate compound; the reaction temperature is -30-60°C; The reaction route is as follows:
2. The method for synthesizing the ketamine intermediate compound according to claim 1, It is characterized in that The oxidant used in the oxidation reaction in step (i) is oxygen or air.
3. The method for synthesizing the ketamine intermediate compound according to claim 1, It is characterized in that The base used in the oxidation reaction in step (i) is potassium hydroxide, potassium carbonate, potassium bicarbonate, cesium carbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium tert-butoxide or sodium tert-butoxide.
4. The method for synthesizing the ketamine intermediate compound according to claim 1, It is characterized in that The reducing agent used in the oxidation reaction in step (i) is sodium sulfite, sodium bisulfite, triethyl phosphite, sodium phosphite, trimethyl phosphite, triisopropyl phosphite or sodium thiosulfate.
5. The method for synthesizing the ketamine intermediate compound according to claim 1, It is characterized in that The reaction time of step (i) is 24h-96h.
6. The method for synthesizing the ketamine intermediate compound according to claim 1, It is characterized in that In step (ii), the sulfonylating agent is methanesulfonic acid, methanesulfonyl chloride, benzenesulfonyl chloride, thionyl chloride or p-toluenesulfonyl chloride.
7. A method for synthesizing ketamine using the ketamine intermediate compound obtained by the method of claim 1, It is characterized in that The method comprises the following steps: (iii) reacting the ketamine intermediate compound with a methylamination reagent to produce ketamine; the reaction temperature is -10-60°C; The reaction route is as follows:
8. The method for synthesizing ketamine according to claim 7, It is characterized in that The methylamine reagent is methylamine-ethanol solution, methylamine-methanol solution, methylamine tetrahydrofuran solution, methylamine aqueous solution or liquid methylamine.
9. A method for synthesizing norketamine using the ketamine intermediate compound obtained by the method of claim 1, It is characterized in that The method comprises the following steps: (iv) reacting the ketamine intermediate compound with an amination reagent to produce norketamine; the reaction temperature is -10-60°C; The reaction route is as follows:
10. The method for synthesizing norketamine according to claim 9, It is characterized in that The amination reagent is ammonia gas, ammonia-methanol solution, ammonia-ethanol solution, ammonia-isopropanol solution or liquid ammonia-tetrahydrofuran solution.
